U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07062380) titled 'AI-Based Prediction of HCC Recurrence Patterns After Resection (APAR)' on July 02.
Brief Summary: This observational study aims to validate a deep learning model for predicting aggressive recurrence patterns in patients with early-stage liver cancer (HCC) after surgery.
The main question it aims to answer is: Can the AI model accurately identify patients at high risk of cancer recurrence within 2 years after surgery? Participants will provide clinical data and undergo standard surgery, followed by 2-year imaging surveillance. Their data will be used for both AI prediction and validation of recurrence patterns.
Study Start Date: Ju...